SCHEMBL20534179

SCHEMBL20534179

[2H]C([2H])(OS(C)(=O)=O)C([2H])([2H])N(c1ccc(C)c(CC(CC(=O)O)NC(=O)OC(C)(C)C)c1)C([2H])([2H])C([2H])([2H])OS(C)(=O)=O

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 6/20 0.35
▸ NPSR1 Q6W5P4 6/20 0.35
▸ LMNA P02545 5/20 0.35
▸ HPGD P15428 5/20 0.35
▸ XBP1 P17861 4/20 0.35
▸ JAK2 O60674 4/20 0.35
▸ ALDH1A1 P00352 4/20 0.35
▸ HSP90AA1 P07900 2/20 0.35
▸ S1PR4 O95977 2/20 0.35
▸ THRB P10828 1/20 0.35
▸ PKM P14618 4/20 0.34
▸ HSD17B10 Q99714 4/20 0.34
▸ TP53 P04637 3/20 0.34
▸ MAPK1 P28482 3/20 0.34
▸ GAA P10253 1/20 0.34
▸ ATM Q13315 2/20 0.34
▸ CTSS P25774 8/20 0.33
▸ CTSK P43235 7/20 0.33
▸ AAK1 Q2M2I8 1/20 0.33
▸ SYK P43405 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18428127 1.00 HTT (0.35) HTTNPSR1LMNAHPGDXBP1
SCHEMBL16974967 0.88 ATM (0.35) HTTNPSR1LMNAHPGDXBP1
SCHEMBL18427935 0.88 ATM (0.35) HTTNPSR1LMNAHPGDXBP1
SCHEMBL18428126 0.87 ATM (0.37) HTTNPSR1LMNAHPGDXBP1
SCHEMBL18427977 0.86 ATM (0.36) HTTNPSR1LMNAHPGDXBP1
SCHEMBL23877862 0.84 AAK1 (0.33) HTTNPSR1LMNAHPGDXBP1
SCHEMBL18428023 0.84 AAK1 (0.33) HTTNPSR1LMNAHPGDXBP1
SCHEMBL16974955 0.84 IDO1 (0.35) HTTNPSR1LMNAHPGDXBP1
SCHEMBL23877849 0.84 IDO1 (0.35) HTTNPSR1LMNAHPGDXBP1
SCHEMBL18428043 0.84 IDO1 (0.35) HTTNPSR1LMNAHPGDXBP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10246406-B2 Beta-substituted beta-amino acids and analogs as chemotherapeutic agents and uses thereof QUADRIGA BIOSCIENCES, INC. (US) 2019-04-02 — — US disclosed
US-20180297935-A1 BETA-SUBSTITUTED BETA-AMINO ACIDS AND ANALOGS AS CHEMOTHERAPEUTIC AGENTS AND USES THEREOF QUADRIGA BIOSCIENCES, INC. 2018-10-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180297935-A1 BETA-SUBSTITUTED BETA-AMINO ACIDS AND ANALOGS AS CHEMOTHERAPEUTIC AGENTS AND USES THEREOF SLC3A2, SLC7A1, SLC43A1 HTT 1685/4885NPSR1 2754/4885LMNA 3589/4885
US-10246406-B2 Beta-substituted beta-amino acids and analogs as chemotherapeutic agents and uses thereof SLC3A2, SLC7A1, SLC43A1 HTT 1685/4885NPSR1 2754/4885LMNA 3589/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback